🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, dulaglutide-controlled, multicenter Phase...
Status
Completed
Location
Peking University People's Hospital
Start Date
2024-04-08
Trial ID
NCT06235086
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
Gao Huanhuan
Start Date
2021-07-01
Trial ID
NCT04855292
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled, ...
Status
Completed
Location
Clinical Trials Information Group
Start Date
2023-11-22
Trial ID
NCT05997576
Treatments Being Tested
The main purposes of this study are to determine: 1. To assess the safety ...
Status
Completed
Location
China-Japan Friendship Hospital
Start Date
2019-07-29
Trial ID
NCT03990090
The primary objective of this trial is to evaluate the efficacy of differen...
Status
Unknown
Location
Gao Huanhuan
Start Date
2022-06-15
Trial ID
NCT05348122
Treatments Being Tested
This is a randomized, double-blind, placebo-parallel, multicenter phase 3 c...
Status
Completed
Location
Peking University People's Hospital
Start Date
2024-04-15
Trial ID
NCT06258148
This study is designed to evaluate the comparability of TG103 injection sub...
Status
Completed
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2021-05-18
Trial ID
NCT04839744
The main purpose of this study is to assess the safety and tolerability of ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04790006
This study is a multicenter, randomized, double-blind, placebo-controlled, ...
Status
Unknown
Location
Baotou City Central Hospital
Start Date
2022-05-20
Trial ID
NCT05299697
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled, parallel phas...
Status
Completed
Location
Clinical Trials Information Group
Start Date
2024-02-21
Trial ID
NCT06226090
Treatments Being Tested